{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:42:48Z","timestamp":1794620568668,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T00:00:00Z","timestamp":1708387200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["515279324"],"award-info":[{"award-number":["515279324"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012353","name":"Deutschen Konsortium f\u00fcr Translationale Krebsforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012353","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lungcan.2024.107507","type":"journal-article","created":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T11:14:30Z","timestamp":1708168470000},"page":"107507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation"],"prefix":"10.1016","volume":"189","author":[{"given":"Kim Melanie","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maksym","family":"Oreshko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Anne","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie Elisabeth","family":"Combs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Caspar","family":"Peeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2024.107507_b0005","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107507_b0010","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1470-2045(17)30380-7","article-title":"Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial","volume":"18","author":"Shaverdian","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0015","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/jamaoncol.2021.6439","article-title":"Association of radiation therapy with risk of adverse events in patients receiving immunotherapy: a pooled analysis of trials in the US Food and Drug Administration Database","volume":"8","author":"Anscher","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0020","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ijrobp.2015.10.002","article-title":"Lung size and the risk of radiation pneumonitis","volume":"94","author":"Briere","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0025","series-title":"Molecular Imaging in Oncology","first-page":"773","article-title":"Image-guided radiooncology: the potential of radiomics in clinical application","author":"Peeken","year":"2020"},{"key":"10.1016\/j.lungcan.2024.107507_b0030","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/cancers12103047","article-title":"Comprehensive analysis of tumour sub-volumes for radiomic risk modelling in locally advanced HNSCC","volume":"12","author":"Leger","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107507_b0035","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1007\/s00259-020-04864-1","article-title":"A CT-based radiomics model to detect prostate cancer lymph node metastases in PSMA radioguided surgery patients","volume":"47","author":"Peeken","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.lungcan.2024.107507_b0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2019.01.004","article-title":"CT-based radiomic features predict tumor grading and have prognostic value in patients with soft tissue sarcomas treated with neoadjuvant radiation therapy","volume":"135","author":"Peeken","year":"2019","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ebiom.2019.08.059","article-title":"Tumor grading of soft tissue sarcomas using MRI-based radiomics","volume":"48","author":"Peeken","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.lungcan.2024.107507_b0050","doi-asserted-by":"crossref","first-page":"10192","DOI":"10.1038\/s41598-022-13967-8","article-title":"Analysis of MRI and CT-based radiomics features for personalized treatment in locally advanced rectal cancer and external validation of published radiomics models","volume":"12","author":"Shahzadi","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2024.107507_b0055","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3390\/cancers13040786","article-title":"Deep learning based HPV status prediction for oropharyngeal cancer patients","volume":"13","author":"Lang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107507_b0060","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.3390\/cancers13122866","article-title":"Development and external validation of deep-learning-based tumor grading models in soft-tissue sarcoma patients using MR imaging","volume":"13","author":"Navarro","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107507_b0065","doi-asserted-by":"crossref","unstructured":"O. Llori\u00e1n-Salvador, J. Akhgar, S.U. Pigorsch, K.J. Borm, S. M\u00fcnch, D. Bernhardt, et al., Machine learning based prediction of pain response to palliative radiation therapy - is there a Role for Planning CT-based Radiomics and Semantic Imaging Features? Preprints 2022 2022. https:\/\/doi.org\/10.20944\/preprints202212.0195.v1).","DOI":"10.20944\/preprints202212.0195.v1"},{"key":"10.1016\/j.lungcan.2024.107507_b0070","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1002\/mp.13150","article-title":"The utility of quantitative CT radiomics features for improved prediction of radiation pneumonitis","volume":"45","author":"Krafft","year":"2018","journal-title":"Med. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0075","doi-asserted-by":"crossref","first-page":"16232","DOI":"10.1038\/s41598-021-95643-x","article-title":"Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis","volume":"11","author":"Kawahara","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lungcan.2024.107507_b0080","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.radonc.2020.10.040","article-title":"Radiomics analysis of 3D dose distributions to predict toxicity of radiotherapy for lung cancer","volume":"155","author":"Bourbonne","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3389\/fonc.2019.00269","article-title":"Dosiomics: extracting 3D spatial features from dose distribution to predict incidence of radiation pneumonitis","volume":"9","author":"Liang","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0090","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.ijrobp.2021.01.049","article-title":"Dosimetric factors and radiomics features within different regions of interest in planning CT images for improving the prediction of radiation pneumonitis","volume":"110","author":"Jiang","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.768152","article-title":"Radiomic and dosiomic features for the prediction of radiation pneumonitis across esophageal cancer and lung cancer","volume":"12","author":"Puttanawarut","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0100","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ijrobp.2022.08.047","article-title":"Radiomics and dosiomics signature from whole lung predicts radiation pneumonitis: a model development study with prospective external validation and decision-curve analysis","volume":"115","author":"Zhang","year":"2023","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0105","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211016373","article-title":"Prediction of radiation pneumonitis with machine learning in stage III lung cancer: a pilot study","volume":"20","author":"Yakar","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.lungcan.2024.107507_b0110","doi-asserted-by":"crossref","first-page":"e1822","DOI":"10.1002\/onco.13900","article-title":"Radiation versus immune checkpoint inhibitor associated pneumonitis: distinct radiologic morphologies","volume":"26","author":"Chen","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.lungcan.2024.107507_b0115","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/mp.15451","article-title":"Differentiation between immune checkpoint inhibitor-related and radiation pneumonitis in lung cancer by CT radiomics and machine learning","volume":"49","author":"Cheng","year":"2022","journal-title":"Med. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejca.2023.01.027","article-title":"Computed tomography-based radiomics for the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer patients treated with immune checkpoint inhibitors","volume":"183","author":"Tohidinezhad","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.lungcan.2024.107507_b0125","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) | Protocol Development | CTEP 2022. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm (accessed March 28, 2022)."},{"key":"10.1016\/j.lungcan.2024.107507_b0130","doi-asserted-by":"crossref","unstructured":"Kraus KM, Oreshko M, Bernhardt D, Combs SE, Peeken JC. Dosiomics and radiomics to predict pneumonitis after thoracic stereotactic body radiotherapy and immune checkpoint inhibition. Frontiers in Oncology 2023;13.","DOI":"10.3389\/fonc.2023.1124592"},{"key":"10.1016\/j.lungcan.2024.107507_b0135","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/aaf26a","article-title":"The linear quadratic model: usage, interpretation and challenges","volume":"64","author":"McMahon","year":"2018","journal-title":"Phys. Med. Biol."},{"key":"10.1016\/j.lungcan.2024.107507_b0140","unstructured":"Radiomics n.d. https:\/\/www.radiomics.io\/index.html (accessed November 23, 2022)."},{"key":"10.1016\/j.lungcan.2024.107507_b0145","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1158\/0008-5472.CAN-17-0339","article-title":"Computational radiomics system to decode the radiographic phenotype","volume":"77","author":"van Griethuysen","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.lungcan.2024.107507_b0150","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1002\/mp.12967","article-title":"Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers","volume":"45","author":"Deist","year":"2018","journal-title":"Med. Phys."},{"key":"10.1016\/j.lungcan.2024.107507_b0155","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1613\/jair.953","article-title":"SMOTE: synthetic minority over-sampling technique","volume":"16","author":"Chawla","year":"2002","journal-title":"Jair"},{"key":"10.1016\/j.lungcan.2024.107507_b0160","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.3390\/cancers14194889","article-title":"Lung subregion partitioning by incremental dose intervals improves omics-based prediction for acute radiation pneumonitis in non-small-cell lung cancer patients","volume":"14","author":"Li","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.lungcan.2024.107507_b0165","doi-asserted-by":"crossref","first-page":"5328927","DOI":"10.1155\/2023\/5328927","article-title":"Machine learning-based multiomics prediction model for radiation pneumonitis","volume":"2023","author":"Zhou","year":"2023","journal-title":"J. Oncol."},{"key":"10.1016\/j.lungcan.2024.107507_b0170","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non\u2013small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2024.107507_b0175","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.3390\/cancers14122948","article-title":"Pneumonitis after stereotactic thoracic radioimmunotherapy with checkpoint inhibitors: exploration of the dose\u2013volume\u2013effect correlation","volume":"14","author":"Kraus","year":"2022","journal-title":"Cancers"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500224000400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:08:53Z","timestamp":1759237733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500224000400"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":35,"alternative-id":["S0169500224000400"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107507","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosiomics and radiomics-based prediction of pneumonitis after radiotherapy and immune checkpoint inhibition: The relevance of fractionation","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2024.107507","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107507"}}